Sheppard, Mullin, Richter & Hampton and Morrison Foerster served as legal counsel to SPA. King & Spalding served as legal counsel and Baird served as the...
You must be a Standard 1 Year member to access this content.
Simpson Thacher & Bartlett LLP and Osborne Clarke advised CBRE Group, Inc., while Sheppard Mullin Richter & Hampton LLP acted for J&J and Arlington Capital Partners....
You must be a Standard 1 Year member to access this content.
Sheppard Mullin advised Arlington Capital Partners and Eqlipse Technologies on the deal. Arlington Capital Partners and its portfolio company Eqlipse Technologies announced its acquisition of UES, Inc.,...
You must be a Standard 1 Year member to access this content.
Sheppard Mullin represented Arlington Capital Partners and its portfolio company BlueHalo on the deal. BlueHalo, a leading provider of critical capabilities and technologies across Space, Air,...
You must be a Standard 1 Year member to access this content.
Sheppard Mullin represented Forged Solutions Group, Inc. on the deal. Forged Solutions Group, Inc., a leading provider of complex, precision forged rings and closed die products...
You must be a Standard 1 Year member to access this content.
Sheppard Mullin represented Arlington Capital Partners and its portfolio company, Forged Solutions Group, Inc. on the deal. Arlington Capital Partners and its portfolio company, Forged Solutions...
You must be a Standard 1 Year member to access this content.
Sheppard Mullin advised Arlington Capital Partners on the deal. Arlington Capital Partners, a Washington, DC-based private equity firm, announced it has, in partnership with the existing...
You must be a Standard 1 Year member to access this content.
Sheppard Mullin advised Arlington Capital Partners on the deal. Arlington Capital Partners (“Arlington Capital”) announced that they have closed on the sale of Molecular Products to...
You must be a Standard 1 Year member to access this content.
Sheppard Mullin advised Arlington Capital Partners on the deal. Arlington Capital Partners (“Arlington Capital”) announced that they have closed on the sale of Molecular Products to...
You must be a Standard 1 Year member to access this content.
